12.80
-0.10
(-0.78%)
As of 9:32:04 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-6,178
-6,178
-4,704
-2,740
-1,022
Investing Cash Flow
-1,490
-1,490
-1,941
-1,512
1,446
Financing Cash Flow
6,425
6,425
1,244
-467
14,427
End Cash Position
3,069
3,069
4,351
9,586
15,001
Capital Expenditure
-1,490
-1,490
-1,941
-1,512
-849
Issuance of Capital Stock
2
2
--
--
15,626
Repayment of Debt
--
--
--
-331
-1,024
Free Cash Flow
-7,668
-7,668
-6,645
-4,252
-1,871
12/31/2020 - 2/22/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
QNNTF Quantum Genomics Société Anonyme
0.1000
0.00%
ELIC.ST Elicera Therapeutics AB (publ)
2.8950
-3.50%
AVTX Avalo Therapeutics, Inc.
5.49
-4.69%
PHM.MC Pharma Mar, S.A.
73.25
-2.72%
ONT.L Oxford Nanopore Technologies plc
101.10
-5.69%
UNCY Unicycive Therapeutics, Inc.
0.4701
+2.02%
ARGX argenx SE
548.93
-0.19%
OSRH OSR Holdings, Inc.
1.5000
-1.96%
CRSP CRISPR Therapeutics AG
31.27
-3.43%
MRNA Moderna, Inc.
24.64
-3.90%